Replies to post #313407 on Avid Bioservices Inc (CDMO)

[biopharm]

I agree and was pointing out "Shenoy" from your original post that he noticed flipped PS and then spent the following many months further researching what they seem to believe is the controlling signal of tumor Microenvironment and followed up with more flipped PS research in July 2017

How many are others are in the midst of PS Targeting research??

Keep cool - it´s from 2015!

Raymond J. KelleherJr1, Sathy Balu-Iyer2, Jenni Loyall1, Anthony J. Sacca1,
Gautam N. Shenoy1, Peng Peng1,Vandana Iyer2, Anas M. Fathallah2,
Charles S. Berenson3, Paul K.Wallace4, Joseph Tario4, Kunle Odunsi5, and
Richard B. Bankert1